Bickling Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bickling Financial Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$934K	Sell	33,087 -4,455	-12%	-$141K	0.58%	35
2022 Q3	$1.24M	Sell	37,542 -894	-2%	-$32.8K	0.83%	30
2022 Q2	$1.21M	Sell	38,436 -988	-3%	-$34.5K	0.77%	31
2022 Q1	$1.81M	Sell	39,424 -3,192	-7%	-$152K	0.93%	25
2021 Q4	$2.61M	Sell	42,616 -6,129	-13%	-$424K	1.27%	20
2021 Q3	$3.64M	Sell	48,745 -4,386	-8%	-$368K	1.85%	15
2021 Q2	$4.92M	Buy	53,131 +32	+0.1%	+$2.72K	2.22%	13
2021 Q1	$4.71M	Buy	53,099 +11,349	+27%	+$1.13M	2.37%	13
2020 Q4	$3.89M	Buy	+41,750	New	+$3.33M	2.4%	11

Other funds holding ARKG

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Bickling Financial Services's ARKG Position: Q4 2022 in Review

Bickling Financial Services reduced its ARK Genomic Revolution ETF (ARKG) stake by 12% in Q4 2022, selling an estimated $141K and leaving 33,087 shares worth $934K. The position accounts for 0.58% of the portfolio, ranked #35.

Bickling Financial Services first reported a position in ARKG in Q4 2020 and has held it in 9 quarters since. The position peaked at $4.92M in Q2 2021. 320 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

Bickling Financial Services held 33,087 shares of ARK Genomic Revolution ETF worth $934K as of Q4 2022.
Bickling Financial Services sold 4,455 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $141K.
ARK Genomic Revolution ETF made up 0.58% of Bickling Financial Services's portfolio in Q4 2022, its #35 holding.
Bickling Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 9 quarters since.
Bickling Financial Services's ARK Genomic Revolution ETF position peaked at $4.92M in Q2 2021.
320 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Bickling Financial Services's 13F filing for Q4 2022, filed 31 Jan 2023.